Eduardo Fernández‐Cruz

Author

Hospital General Universitario Gregorio Marañón

Also Known As

Adrian Siles, Antoni Trilla, Carmen Bracke, David Dalmau, E FERNÁNDEZ‐CRUZ, E Fernandez-Cruz, E Fernandez-cruz, E Fernndez-Cruz, E Fernández-Cruz, E Fernández‐Cruz

187

Publications

4.2K

Citations

H-Index

121

Concepts

All Affiliations

Hospital General Universitario Gregorio Marañón Universidad Complutense de Madrid Hospital Clínico San Carlos Hospital Universitario La Paz

About

Eduardo Fernández‐Cruz is an author at Hospital General Universitario Gregorio Marañón specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	46	1.9K
2	Allergy	10	10	233
3	Public Health	5	5	278
4	Health Sciences	3	3	97
5	Allergy Medicine	1	1	11

Eduardo Fernández‐Cruz

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes. Eduardo Fernández‐Cruz, Bruce A. Woda, J D Feldman The Journal of Experimental Medicine Bn RatsCancer ImmunosurveillanceT Cell SubsetSyngeneic SarcomasSubcutaneous Moloney Sarcomas	1980	141
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial Richard T. Davey, Eduardo Fernández‐Cruz, Norman Markowitz, The Lancet Respiratory Medicine	2019	132
Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: An ex vivo and in vitro longitudinal study in relapsing−remitting multiple sclerosis Clara de Andrés, Carol Aristimuño, Virginia de las Heras, Journal of Neuroimmunology Autoimmune DiseaseImmune DysregulationMedicineT-regulatory CellImmune Regulation	2006	128
Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial Thomas L Holland, Adit A. Ginde, Roger Paredes, The Lancet Respiratory Medicine Covid-19 PandemicAntiviral TherapyClinical TrialsCovid-19 EpidemiologyMedicine	2022	124
Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case-control study Rosario Cobo-Soriano, Silvia Sánchez‐Ramón, M.Jesús Aparicio, American Journal of Ophthalmology ThrombosisOcular DiseaseVenous ThrombosisOphthalmologyCardiovascular Disease	1999	115
Intravenous Immunoglobulin Treatment Increased Live Birth Rate in a <scp>S</scp>panish Cohort of Women with Recurrent Reproductive Failure and Expanded <scp>CD</scp>56<sup>+</sup> Cells Manuela Moraru, Javier Carbone, Diana Alecsandru, American Journal of Reproductive Immunology	2012	100
Quantitative Alterations of the Functionally Distinct Subsets of CD4 and CD8 T Lymphocytes in Asymptomatic HIV Infection José M. Benito, J M Zabay, Juana Gil, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology	1997	86
Pregnancy-induced expansion of regulatory T-lymphocytes may mediate protection to multiple sclerosis activity Silvia Sánchez‐Ramón, Joaquín Navarroa, Carol Aristimuño, Immunology Letters Maternal ImmunizationRegulatory T-lymphocytesAutoimmune DiseaseMedicineT-regulatory Cell	2004	76
Increased levels of activated subsets of CD4 T cells add to the prognostic value of low CD4 T cell counts in a cohort of HIV-infected drug users Javier Carbone, Juana Gil, José M. Benito, AIDS	2000	75
Outcomes of splenectomy in patients with common variable immunodeficiency (CVID): a survey of 45 patients Gabriel K.Y. Wong, Sigune Goldacker, C Winterhalter, Clinical & Experimental Immunology	2012	73

Page 1